LungenClinic Grosshansdorf
Specialist lung hospital near Hamburg whose thoracic oncology department, under Martin Reck, has led many of the pivotal immunotherapy trials in lung cancer, including KEYNOTE-024.
Overview
LungenClinic Grosshansdorf is a specialist hospital for lung disease outside Hamburg and a site of the German Center for Lung Research (Airway Research Center North). Its Department of Thoracic Oncology, headed by Martin Reck, was the lead centre for KEYNOTE-024, the 2016 trial that established first-line pembrolizumab for PD-L1-high non-small-cell lung cancer, and has contributed to most large lung cancer immunotherapy and small-cell lung cancer trials since.
- Thoracic oncology
- Lung cancer immunotherapy trials
- Small-cell lung cancer
Similar pages
not linked directly; found by shared links- PersonMatthew D. Hellmann
Shares Lung cancer (all types), PD-L1-high non-small-cell lung cancer without a driver mutation, Non-small-cell lung cancer.
- TrialKEYNOTE-407
Shares Lung cancer (all types), PD-L1-high non-small-cell lung cancer without a driver mutation, Non-small-cell lung cancer.
- TrialCheckMate 227
Shares Lung cancer (all types), PD-L1-high non-small-cell lung cancer without a driver mutation, Non-small-cell lung cancer.
- PersonAlice T. Shaw
- TrialA Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
Shares PD-L1-high non-small-cell lung cancer without a driver mutation, Non-small-cell lung cancer.
- TrialThis is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lu
Shares PD-L1-high non-small-cell lung cancer without a driver mutation, Non-small-cell lung cancer.
- TrialA Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Shares PD-L1-high non-small-cell lung cancer without a driver mutation, Non-small-cell lung cancer.
- PersonGregory J. Riely